Newsy's Latest Health News

Moderna has requested FDA approval to extend its COVID-19 vaccine use to children aged 12-17, claiming 100% efficacy in trials. This would make it the second vaccine available for kids before the school year. Experts emphasize the importance of vaccinating children to boost immunity rates. Meanwhile, Johnson & Johnson's vaccine shelf life has been extended by six weeks, allowing storage for up to four and a half months, which helps prevent dose wastage as demand decreases. Kaiser Health News provides these updates.

What new insight or understanding did you gain from this video?